companies developing glp 1 drugs India pharma develop versions of Wegovy to get in on weight-loss windfall companies developing glp-1 drugs Beyond
Description
Zheng D, Li N, Hou R, et al
Zealand and Boehringer Ingelheim have survodutide in Phase 3 trials and is included in the GLP1 Pipeline Update
Cai CX, Hribar M, Baxter S, Goetz K, Swaminathan SS, Flowers A, et al
There is also a concern about long term effects, so people with a history of pancreatitis, for example, would be unlikely to be prescribed a GLP-1
Unlike diabetes, which is widely accepted as a chronic condition requiring ongoing pharmacologic management, obesity treatment often lacks the same framing, leading to premature discontinuation
